Alternative Medicine Modalities for Primary Health Care: A Primer
In recent years, there has been growing interest in alternative medicine modalities as complementary options to conventional primary health care. These modalities... Read more.
US Impose Fentanyl-related Sanctions on Sinaloa Members, Mexico-based Entities
The United States’ decision to impose sanctions on 15 Sinaloa Cartel members and six Mexico-based entities marks a significant escalation in efforts to combat... Read more.
How Safety Innovations are Transforming Healthcare
In the quickly evolving landscape of healthcare, safety innovations stand at the very front of transforming patient care and functional proficiency. From groundbreaking... Read more.
Testosterone Replacement Therapy Market to Reach $2.9 Billion Globally, By 2032
The Testosterone Replacement Therapy (TRT) market is poised for significant growth, with a projected global value of $2.9 billion by 2032, reflecting a compound... Read more.
Global Menopause Market Analysis Report 2024
The Global Menopause Market is projected to witness substantial growth, with an expected market size of USD 24.4 billion by 2030, reflecting a compound annual growth... Read more.
The Impact of Addictive Drugs on Mental Health: Insights from Washington State
Today, in an era that is marked by increasing awareness of mental health challenges, getting to understand the intricate relationship between addictive drugs and... Read more.
How mental health counselors maintain safe medication practices
Mental health counselors are essential in helping people with their emotional problems and promoting change in their behavior. They teach their patients communication... Read more.
Global Parenteral Nutrition Market Expected to Reach $11.47 Billion by 2030
Research and Markets, a leading market research firm, has recently released a comprehensive report titled “Parenteral Nutrition Market: Global Industry Analysis,... Read more.
The US FDA Rejects Viatris’s Injection for Multiple Sclerosis
The U.S. Food and Drug Administration (FDA) has declined to approve Viatris and Mapi Pharma’s once-a-month injection intended for treating relapsing forms... Read more.
Madrigal Pharma Shares Surges After Drug Wins First Approval For Fatty Liver Disease NASH
Madrigal Pharmaceuticals (MDGL.O) experienced a significant surge in its stock value, jumping by as much as 23% on Friday, following the approval of its oral drug,... Read more.